|
|
DEVELOPING REMYELINATION STRATEGIES FOR DEMYELINATING OPTIC NEUROPATHIES USING HUMAN PLURIPOTENT STEM CELLS |
| 1K99EY029011-01A1 |
CHAMLING, XITIZ |
NEI |
2019 |
|
|
ROLE OF TYPE 2 INNATE LYMPHOID CELLS (ILC2S) IN OPTIC NEURITIS |
| 1R01EY029677-01 |
GHIASI, HOMAYON |
NEI |
2019 |
|
|
BIOMARKERS OF VISION LOSS IN CHILDREN WITH OPTIC PATHWAY GLIOMAS |
| 1R01EY029687-01 |
AVERY, ROBERT ANDREW |
NEI |
2019 |
|
|
DEVELOPMENT OF IMMUNOLOGIC THERAPIES AGAINST UVEITIS |
| 1ZIAEY000350-20 |
EGWUAGU, CHARLES E |
NEI |
2019 |
|
|
MECHANISMS OF IMMUNE HOMEOSTASIS AND REGULATION OF INTRAOCULAR INFLAMMATION |
| 1ZIAEY000372-19 |
EGWUAGU, CHARLES E |
NEI |
2019 |
|
|
NEUROVASCULAR AND NEUROPLASTIC CONTRIBUTIONS TO VISUAL RECOVERY AFTER STROKE |
| 5F30EY027988-02 |
SCHNEIDER, COLLEEN L |
NEI |
2019 |
|
|
DEVELOPING ALTERNATIVE APPROACHES TO REDUCE RETINAL TOXICITY AND PREVENT VISION LOSS IN THE TREATMENT OF INTRAOCULAR RETINOBLASTOMA |
| 5K08EY027464-03 |
DANIELS, ANTHONY BRENT |
NEI |
2019 |
|
|
IDENTIFICATION OF A NOVEL PATHWAY THAT REGULATES OPTIC NERVE MYELINATION AND REMYELINATION |
| 5K99EY029330-02 |
SUN, LU |
NEI |
2019 |
|
|
AQUAPORIN-4 IN NMO OPTIC NEURITIS: PATHOGENESIS AND NEW THERAPIES |
| 5R01EY013574-17 |
VERKMAN, ALAN S |
NEI |
2019 |
|
|
COGNITIVE NEURAL PROSTHETICS FOR CLINICAL APPLICATIONS |
| 5R01EY015545-14 |
ANDERSEN, RICHARD A |
NEI |
2019 |
